Elsevier, a global leader in research publishing and information analytics, has announced the launch of an enhanced version of ClinicalKey®, which will provide physicians with quick access to Elsevier’s trusted medical resources in addition to clinical decision support at the point of care. The new ClinicalKey for physicians in the U.S. and various international markets will help them diagnose and treat patients faster, and more effectively, based on the latest evidence.
This enhancement is coming as time-pressed clinicians are facing the daunting task of having to keep current with a high volume of medical research output. The rate at which medical knowledge has been expanding in recent history is exponential. In 1950, the total amount of medical research doubled in approximately 50 years. This accelerated to 7 years in 1980; 3.5 years in 2010; and just 73 days in 20201. Recognizing this issue, Elsevier conducted extensive research with hundreds of clinicians and leveraged global insights to inform the development of a solution that would support them with patient care in an environment where evidence-based data and guidance changes quickly.
Elsevier also partnered with institutional leaders to evolve ClinicalKey and help address these challenges.
While ClinicalKey will retain all current elements and functionality as a reference resource, it now includes new features that make it easier to use for clinical decision support, such as: New user interface; Improved search functionality; and Significant Point of Care content.
Elsevier has been working continuously to enhance its global portfolio of clinical solutions, making these tools more responsive and accessible at the point of care.
During the process of building and enhancing ClinicalKey, local solutions in specific international regions have also been developed. These include ClinicalKey China, and ClinicalKey Now, a solution that responds to needs in key local markets outside of the U.S., so that they can have confidence in their decisions to sustain continuity of care for patients. Other products in Elsevier’s portfolio include ClinicalPath, an evidence-based oncology pathways embedded in the clinical workflow to allow oncology practices to predict, measure and manage treatment decisions and costs, and Elsevier Clinical Nursing which combines trusted evidence and technology to empower nurses to excel.
Click here to read the original press release.
